Chiesi Ltd.
Chiesi Ltd., a subsidiary of the Chiesi Group, is a prominent player in the global pharmaceutical industry, headquartered in Great Britain. Founded in 1935, the company has established itself as a leader in the development of innovative therapies, particularly in the fields of respiratory, neonatology, and rare diseases. With a strong presence across Europe and expanding operations in other regions, Chiesi Ltd. is committed to improving patient outcomes through its unique portfolio of products.
The company is renowned for its cutting-edge inhalation therapies and advanced drug delivery systems, which set it apart in a competitive market. Chiesi Ltd. has achieved significant milestones, including recognition for its sustainable practices and commitment to research and development. As a result, it holds a notable position within the pharmaceutical sector, dedicated to enhancing the quality of life for patients worldwide.
+33 vs industry average
Chiesi Ltd.’s score of 73 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Chiesi Ltd.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has typical carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Chiesi Ltd. yet.
Chiesi Ltd.'s reported carbon emissions
Chiesi Ltd., headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Chiesi Farmaceutici S.p.A., any climate commitments or emissions data would be inherited from this parent organization.
Chiesi Farmaceutici S.p.A. has established various climate initiatives, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Chiesi Ltd. have not been disclosed.
As part of its climate strategy, Chiesi Farmaceutici S.p.A. is actively working towards reducing its carbon footprint and enhancing sustainability practices across its operations. The company is committed to aligning its efforts with industry standards and best practices in climate action, although detailed metrics and targets specific to Chiesi Ltd. remain unspecified at this time.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Chiesi Ltd.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Chiesi Ltd. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Chiesi Farmaceutici S.p.A.
Carbon Disclosure Project
Inherited from Chiesi Farmaceutici S.p.A.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Chiesi Farmaceutici S.p.A.RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Chiesi Ltd. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project